πŸ‡ΊπŸ‡Έ FDA
Patent

US 7834000

CGRP receptor antagonists

granted A61PA61P11/06A61P25/02

Quick answer

US patent 7834000 (CGRP receptor antagonists) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P11/06, A61P25/02, A61P25/06, A61P25/08